| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4026118 | Ophthalmology | 2014 | 7 Pages |
Abstract
Overall, SMILE had acceptable safety. Although 1.5% of eyes had reduced CDVA by 3 months, visual acuity was restored in the long term. Likewise, patient satisfaction was high.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Anders MD, PhD, Sven MD, DMSci, Jesper MD, DMSci,